Chen D S.Mellman I. Oncology meets immunology:the cancer-immunity cycle[J].Immunity,2013,39(1):1-10.
[4]
Hanahan D,Weinberg R A. Hallmarks of cancer; the next generation[J].Cell,2011,144(5):646-674.
[5]
Wakabayashi O,Yamazaki K,Oizumi S,et al. CD4(+)T cells in cancer stroma,not CD8(+) T cells in cancer cell nests,are associated with favorable prognosis in human non-small cell lung[J]. cancer sci,2003, 94(11): 1003-1009.
[6]
Villegas FR, Coca S,Villarrubia VG,et al. Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer[J]. Lung Cancer, 2002,35(1): 23-28.
[7]
Furukawa T,Watanabe S,Kodama T,et al.T-zone histiocytes in adenocarcinoma of the lung in relation to postoperative prognosis[J].Cancer,1985,56:2651-2657.
[8]
Mami-Chouaib F,Ech chakir H,Dorothee G,et al.Antitumor cytotoxic T-lymphocyte response in human lung carcinoma:identification of a tumor-associated antigen[J].Immunol Rev,2002,188:114-121.
[9]
Tsujitani S,Kakeji Y,Watanabe A,et al.Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer[J].Cancer,1990,66:2012-2016.
[10]
Fietta P,Delsante G . Focus on human natural kills[J].RivBiol,2009,102(2):219-235.
[11]
Sun JC,Beilke JN,LanierLL.Adaptive immune features of nat2 ural killer cells[J].Naure,2009,457(7229):557-561.
[12]
Benjn in JE,Gill s,Negrin RS.Biology and clinical effects of nstural killer cells in albgeneic transplantation[J].CurrOpin Oncol,2010,22(2):130-137.
[13]
De Santis D ,Foley BA, John E, et al. Rapid, flow cytometric assay for NK alloreactivity reveals exception to rules goveming a12 loreactivity[J].Biol Blood Marrow transplant,2010,16(2):179-191.
[14]
Gattinoni L,Klebanoff CA,Palmer DC,et al.Acquisition of full effector function in Vitroparadoxically impairs the in vivo antitumor effeacy of adoptively transferred CD8 + T cells[J]. clin invest,2005,115（6）：1616-1626.
